 |
Fast Forward, the US National MS Society’s subsidiary devoted to bridging the gap between research and drug development, has chosen IntraLinks, a leading provider of critical information exchange solutions to help streamline the collection, distribution and tracking of information needed to support its funding of multiple biotechnology and pharmaceutical companies who are working on new MS treatments.
To read more, as reported by the US National MS Society, click here.
Source: US National MS Society
|
